Leah M Backhus1, Farhood Farjah2, Steven B Zeliadt3, Thomas K Varghese2, Aaron Cheng2, Larry Kessler4, David H Au5, David R Flum6. 1. Surgery Service, VA Puget Sound Health Care System, Seattle, Washington; Division of Cardiothoracic Surgery, Department of Surgery, University of Washington, Seattle, Washington. Electronic address: lbackhus@u.washington.edu. 2. Division of Cardiothoracic Surgery, Department of Surgery, University of Washington, Seattle, Washington. 3. Health Services Research and Development Service, VA Puget Sound Health Care System, Seattle, Washington; Department of Health Services, School of Public Health, University of Washington, Seattle, Washington. 4. Department of Health Services, School of Public Health, University of Washington, Seattle, Washington. 5. Division of Pulmonary and Critical Care, Department of Medicine, University of Washington, Seattle, Washington. 6. Department of Surgery, University of Washington, Seattle, Washington.
Abstract
BACKGROUND: Current guidelines recommend routine imaging surveillance for patients with non-small cell lung cancer (NSCLC) after treatment. Little is known about surveillance patterns for patients with surgically resected early-stage lung cancer in the community at large. We sought to characterize surveillance patterns in a national cohort. METHODS: We conducted a retrospective study using the Surveillance, Epidemiology, and End-Results (SEER)-Medicare database (1995-2010). Patients with stage I/II NSCLC treated with surgical resection were included. Our primary outcome was receipt of imaging between 4 and 8 months after the surgical procedure. Covariates included demographics and comorbidities. RESULTS: Chest radiography (CXR) was the most frequent initial modality (60%), followed by chest computed tomography (CT) (25%). Positron emission tomography (PET) was least frequent as an initial imaging modality (3%). A total of 13% of patients received no imaging within the initial surveillance period. Adherence to National Comprehensive Cancer Network (NCCN) guidelines for imaging by overall prevalence was 47% for receipt of CT; however, rates of CT increased over time from 28% to 61% (p < 0.01). Reduced rates of CT were associated with stage I disease and surgical resection as the sole treatment modality. CONCLUSIONS: Imaging after definitive surgical treatment for NSCLC predominantly used CXR rather than CT. Most of this imaging is likely for surveillance, and in that context CXR has inferior detection rates for recurrence and new cancers. Adherence to guideline-recommended CT surveillance after surgical treatment is poor, but the reasons are multifactorial. Efforts to improve adherence to imaging surveillance must be coupled with greater evidence demonstrating improved long-term outcomes.
BACKGROUND: Current guidelines recommend routine imaging surveillance for patients with non-small cell lung cancer (NSCLC) after treatment. Little is known about surveillance patterns for patients with surgically resected early-stage lung cancer in the community at large. We sought to characterize surveillance patterns in a national cohort. METHODS: We conducted a retrospective study using the Surveillance, Epidemiology, and End-Results (SEER)-Medicare database (1995-2010). Patients with stage I/II NSCLC treated with surgical resection were included. Our primary outcome was receipt of imaging between 4 and 8 months after the surgical procedure. Covariates included demographics and comorbidities. RESULTS: Chest radiography (CXR) was the most frequent initial modality (60%), followed by chest computed tomography (CT) (25%). Positron emission tomography (PET) was least frequent as an initial imaging modality (3%). A total of 13% of patients received no imaging within the initial surveillance period. Adherence to National Comprehensive Cancer Network (NCCN) guidelines for imaging by overall prevalence was 47% for receipt of CT; however, rates of CT increased over time from 28% to 61% (p < 0.01). Reduced rates of CT were associated with stage I disease and surgical resection as the sole treatment modality. CONCLUSIONS: Imaging after definitive surgical treatment for NSCLC predominantly used CXR rather than CT. Most of this imaging is likely for surveillance, and in that context CXR has inferior detection rates for recurrence and new cancers. Adherence to guideline-recommended CT surveillance after surgical treatment is poor, but the reasons are multifactorial. Efforts to improve adherence to imaging surveillance must be coupled with greater evidence demonstrating improved long-term outcomes.
Authors: Matthias Adrianus Wilhelmus Merkx; Joris Jan Martijn van Gulick; Henri August Marie Marres; Johannus Hendrikus Antonius Maria Kaanders; Ingolv Bruaset; André Verbeek; Peter Christianus Martinus de Wilde Journal: Head Neck Date: 2006-01 Impact factor: 3.147
Authors: Hiroshi Sugimura; Francis C Nichols; Ping Yang; Mark S Allen; Stephen D Cassivi; Claude Deschamps; Brent A Williams; Peter C Pairolero Journal: Ann Thorac Surg Date: 2007-02 Impact factor: 4.330
Authors: Rachel Benamore; Frances A Shepherd; Natasha Leighl; Melania Pintilie; Milan Patel; Ronald Feld; Stephen Herman Journal: J Thorac Oncol Date: 2007-04 Impact factor: 15.609
Authors: Talya Salz; Morris Weinberger; John Z Ayanian; Noel T Brewer; Craig C Earle; Jennifer Elston Lafata; Deborah A Fisher; Bryan J Weiner; Robert S Sandler Journal: BMC Health Serv Res Date: 2010-09-01 Impact factor: 2.655
Authors: Terry S Field; Chyke Doubeni; Matthew P Fox; Diana S M Buist; Feifei Wei; Ann M Geiger; Virginia P Quinn; Timothy L Lash; Marianne N Prout; Marianne Ulcickas Yood; Floyd J Frost; Rebecca A Silliman Journal: J Gen Intern Med Date: 2007-12-01 Impact factor: 5.128
Authors: Michael J Hassett; Matthew Banegas; Hajime Uno; Shicheng Weng; Angel M Cronin; Maureen O'Keeffe Rosetti; Nikki M Carroll; Mark C Hornbrook; Debra P Ritzwoller Journal: J Oncol Pract Date: 2019-05-20 Impact factor: 3.840
Authors: Jyoti Malhotra; Lisa E Paddock; Yong Lin; Sharon R Pine; Muhammad H Habib; Antoinette Stroup; Sharon Manne Journal: J Cancer Surviv Date: 2022-03-22 Impact factor: 4.442
Authors: Lucas W Thornblade; Michael S Mulligan; Katherine Odem-Davis; Billanna Hwang; Rachel L Waworuntu; Erika M Wolff; Larry Kessler; Douglas E Wood; Farhood Farjah Journal: Ann Thorac Surg Date: 2018-07-19 Impact factor: 4.330
Authors: Leah M Backhus; Farhood Farjah; Chao-Kang Jason Liang; Hao He; Thomas K Varghese; David H Au; David R Flum; Steven B Zeliadt Journal: J Surg Res Date: 2015-06-25 Impact factor: 2.192
Authors: Debra P Ritzwoller; Paul A Fishman; Matthew P Banegas; Nikki M Carroll; Maureen O'Keeffe-Rosetti; Angel M Cronin; Hajime Uno; Mark C Hornbrook; Michael J Hassett Journal: Health Serv Res Date: 2018-07-24 Impact factor: 3.402
Authors: Rhami Khorfan; David T Cooke; Robert A Meguid; Leah Backhus; Thomas K Varghese; Farhood Farjah; Karl Y Bilimoria; David D Odell Journal: J Thorac Cardiovasc Surg Date: 2020-07-29 Impact factor: 6.439